Vimarsana
Biggest News Aggregation in the World

Page 2 - 12665010 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 12665010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 12665010 Today - Breaking & Trending Today

U.S. Capital Wealth Advisors LLC Grows Stock Position in CVS Health Co. (NYSE:CVS) - Vimarsana News

U.S. Capital Wealth Advisors LLC Grows Stock Position in CVS Health Co. (NYSE:CVS)

U.S. Capital Wealth Advisors LLC lifted its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 682.9% during the fourth quarter, HoldingsChannel reports. The firm owned 80,407 shares of the pharmacy operator’s stock after purchasing an additional 70,137 shares during the quarter. U.S. Capital Wealth Advisors LLC’s holdings in CVS Health were […]

Avalon Trust Co Decreases Position in CVS Health Co. (NYSE:CVS) - Vimarsana News

Avalon Trust Co Decreases Position in CVS Health Co. (NYSE:CVS)

Avalon Trust Co lowered its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 0.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 300,785 shares of the pharmacy operator’s stock after selling 835 shares during the quarter. CVS Health accounts for […]

Mizuho Cuts CVS Health (NYSE:CVS) Price Target to $72.00 - Vimarsana News

Mizuho Cuts CVS Health (NYSE:CVS) Price Target to $72.00

CVS Health (NYSE:CVS – Free Report) had its price objective cut by Mizuho from $86.00 to $72.00 in a report released on Thursday morning, Benzinga reports. They currently have a buy rating on the pharmacy operator’s stock. Several other equities analysts have also recently issued reports on CVS. StockNews.com cut CVS Health from a buy […]

CVS Health (NYSE:CVS) Price Target Cut to $72.00 - Vimarsana News

CVS Health (NYSE:CVS) Price Target Cut to $72.00

CVS Health (NYSE:CVS – Free Report) had its target price decreased by Mizuho from $86.00 to $72.00 in a research report released on Thursday morning, Benzinga reports. Mizuho currently has a buy rating on the pharmacy operator’s stock. CVS has been the subject of several other reports. Royal Bank of Canada cut their target price […]

Source: wkrb13.com
The Goldman Sachs Group Lowers CVS Health (NYSE:CVS) Price Target to $74.00 - Vimarsana News

The Goldman Sachs Group Lowers CVS Health (NYSE:CVS) Price Target to $74.00

CVS Health (NYSE:CVS – Free Report) had its price objective reduced by The Goldman Sachs Group from $85.00 to $74.00 in a research note issued to investors on Thursday, Benzinga reports. They currently have a buy rating on the pharmacy operator’s stock. A number of other brokerages have also weighed in on CVS. SVB Leerink […]